Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.
Condition(s):SarcomaLast Updated:April 12, 2023Completed
Hide Studies Not Open or Pending
Condition(s):SarcomaLast Updated:April 12, 2023Completed
Condition(s):Esophageal CancerLast Updated:November 4, 2019Unknown status
Condition(s):SarcomaLast Updated:December 22, 2020Withdrawn
Condition(s):Cytomegalovirus InfectionLast Updated:January 25, 2018Completed
Condition(s):Ovarian Cancer; Peritoneal Cavity CancerLast Updated:May 7, 2010Completed
Condition(s):Melanoma (Skin)Last Updated:October 1, 2015Completed
Condition(s):Neuroblastoma; Diffuse Intrinsic Pontine GliomaLast Updated:September 28, 2023Recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:August 16, 2021Terminated
Condition(s):NSCLC Stage IIIA/BLast Updated:January 15, 2019Suspended
Condition(s):Breast Neoplasms; Neoplasm MetastasisLast Updated:July 22, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.